This is an aggregated industry headline. Read the full story at FiercePharma →
ARS Pharma drafts NFL legend Drew Brees in allergy awareness push
The former quarterback spoke with Fierce Pharma Marketing on teaming up with ARS, his journey with food allergies and why needle-free epinephrine Neffy is an "incredible option."
By FiercePharma
· Jul 23, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
Australian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.- but up to a fifth of the…
The WeekBriefing
FDA clears GSK’s Jideytro, the company’s first lung cancer drug, marking a swift return on its $10.6B Nuvalent…
The WeekSTAT News ↗
Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the s…